These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 38712813)
1. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition. Xu C; Hou P; Li X; Xiao M; Zhang Z; Li Z; Xu J; Liu G; Tan Y; Fang C Cancer Biol Med; 2024 May; 21(5):363-81. PubMed ID: 38712813 [TBL] [Abstract][Full Text] [Related]
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
3. Perspective of mesenchymal transformation in glioblastoma. Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019 [TBL] [Abstract][Full Text] [Related]
4. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein. Zarkoob H; Taube JH; Singh SK; Mani SA; Kohandel M PLoS One; 2013; 8(5):e64169. PubMed ID: 23734191 [TBL] [Abstract][Full Text] [Related]
5. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773 [TBL] [Abstract][Full Text] [Related]
6. Current Insights into Mesenchymal Signatures in Glioblastoma. Matsumoto Y; Ichikawa T; Kurozumi K; Date I Acta Med Okayama; 2022 Oct; 76(5):489-502. PubMed ID: 36352795 [TBL] [Abstract][Full Text] [Related]
7. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507 [TBL] [Abstract][Full Text] [Related]
8. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
9. Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses. Yuan F; Yi L; Hai L; Wang Y; Yang Y; Li T; Tong L; Ma H; Liu P; Ming H; Ren B; Yu S; Lin Y; Yang X Dis Markers; 2019; 2019():7049294. PubMed ID: 31772693 [TBL] [Abstract][Full Text] [Related]
10. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Wenger A; Ferreyra Vega S; Kling T; Bontell TO; Jakola AS; Carén H Neuro Oncol; 2019 May; 21(5):616-627. PubMed ID: 30668814 [TBL] [Abstract][Full Text] [Related]
11. FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma. Chen C; Han G; Li Y; Yue Z; Wang L; Liu J J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501 [TBL] [Abstract][Full Text] [Related]
12. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping. Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G Commun Biol; 2019; 2():315. PubMed ID: 31453379 [TBL] [Abstract][Full Text] [Related]
13. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Gill BJ; Pisapia DJ; Malone HR; Goldstein H; Lei L; Sonabend A; Yun J; Samanamud J; Sims JS; Banu M; Dovas A; Teich AF; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sims PA; Canoll P Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12550-5. PubMed ID: 25114226 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma. Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251 [TBL] [Abstract][Full Text] [Related]
15. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma. Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352 [TBL] [Abstract][Full Text] [Related]
16. CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells. Drachsler M; Kleber S; Mateos A; Volk K; Mohr N; Chen S; Cirovic B; Tüttenberg J; Gieffers C; Sykora J; Wirtz CR; Mueller W; Synowitz M; Martin-Villalba A Cell Death Dis; 2016 Apr; 7(4):e2209. PubMed ID: 27124583 [TBL] [Abstract][Full Text] [Related]
17. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models. Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830 [TBL] [Abstract][Full Text] [Related]
18. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective. Wang L; Li X; Xu C; Wang D; Ma C; Wang Z; Li Y; Li Z J Transl Med; 2024 Jun; 22(1):551. PubMed ID: 38851695 [TBL] [Abstract][Full Text] [Related]
19. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma. Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]